FDA Approves Gilenya for Multiple Sclerosis
Links shared publicly online about this topic
Multiple Sclerosis Drug Gilenya (Fingolimod) Approved By FDA
medicalnewstoday.com — “Gilenya (fingolimod) 0.5 mg daily for the treatment of relapsing forms of multiple sclerosis has been approved by the Food and Drug Administration. Swiss pharmaceutical company, Novartis, says tha” View full resource at medicalnewstoday.com
Most Recently Shared on September 22, 2010 at 6:37 pm By:
Multiple Sclerosis Drug Gilenya (Fingolimod) Approved By FDA Gilenya (fingolimod) 0.5 mg daily for the treatment of rel.. http://dld.bz/wCXT
Gilenya Approved for Relapsing MS
everydayhealth.com — “Oral drug designed to slow progressive disability” View full resource at everydayhealth.com
Most Recently Shared on September 23, 2010 at 12:30 am By:
New drug approved by #FDA for relapsing MS http://ow.ly/2IkkJ #multiplesclerosis
Gilenya approved for multiple sclerosis - MPR
empr.com — “The FDA has approved Gilenya (fingolimod capsules, from Novartis), a sphingosine 1-phosphate receptor modulator indicated for the treatment of patients with relapsing forms of multiple sclerosis to reduce the frequency of clinical exacerbations and to delay the accumulation of physical disability.” View full resource at empr.com
Most Recently Shared on September 22, 2010 at 2:07 pm By:
MPR News: Gilenya approved for multiple sclerosis: The FDA has approved Gilenya (fingolimod capsules, from Novarti... http://bit.ly/bNY0nL
Gilenya approved for multiple sclerosis - ONA
oncologynurseadvisor.com — “The FDA has approved Gilenya (fingolimod capsules, from Novartis), a sphingosine 1-phosphate receptor modulator indicated for the treatment of patients with relapsing forms of multiple sclerosis to reduce the frequency of clinical exacerbations and to delay the accumulation of physical disability.” View full resource at oncologynurseadvisor.com
Most Recently Shared on September 22, 2010 at 2:55 pm By:
OncologyNurseAdvisor Oncology, Nursing, Medical Education, and Medical Publisher
Gilenya approved for multiple sclerosis http://goo.gl/fb/E9hlT
Multiple Sclerosis Drug Gilenya (Fingolimod) Approved By FDA - QualityPoint Technologies
qualitypointtech.net — “Gilenya (fingolimod) 0.5 mg daily for the treatment of relapsing forms of multiple sclerosis has been approved by the Food and Drug Administration. Swiss pharmaceutical company, Novartis, says that Gilenya is the first oral medication indicated for relapsing forms of multiple sclerosis (MS) in the United States - it reduces the frequency of MS flare-up, as well as helping slow down the build-up of some of the physical problems associated with MS. Clinical trials involving 2,600 patients demonstr” View full resource at qualitypointtech.net
Most Recently Shared on September 22, 2010 at 7:12 pm By:
Multiple Sclerosis Drug Gilenya (Fingolimod) Approved By FDA: Gilenya (fingolimod) 0.5 mg daily for the treatment ... http://bit.ly/dxL7QD
Multiple Sclerosis Drug Gilenya Approved in Russia | ThirdAge
thirdage.com — “The Multiple Sclerosis drug, Gilenya, manufactured by Novartis has been approved for use in Russia. The drug is a daily oral therapy for treating relapses of multiple sclerosis. Russia is the first country to approve the use of the drug for treating MS.” View full resource at thirdage.com
Most Recently Shared on September 16, 2010 at 1:28 am By:
Multiple Sclerosis Drug Gilenya Approved in Russia: The Multiple Sclerosis drug, Gilenya, manufactured by Novartis... http://bit.ly/buTAb7
Multiple Sclerosis Drug Gilenya Approved in Russia | ThirdAge
thirdage.com — “The Multiple Sclerosis drug, Gilenya, manufactured by Novartis has been approved for use in Russia. The drug is a daily oral therapy for treating relapses of multiple sclerosis. Russia is the first country to approve the use of the drug for treating MS.” View full resource at thirdage.com
Most Recently Shared on September 15, 2010 at 11:26 pm By:
Multiple Sclerosis Drug Gilenya Approved in Russia http://bit.ly/b5Wg6T
FDA Approves Novartis Multiple Sclerosis Drug - Forbes.com
forbes.com — “The Food and Drug Administration approves orally administered multiple sclerosis drug Gilenya.” View full resource at forbes.com
Most Recently Shared on September 22, 2010 at 8:07 pm By:
FDA Approves Novartis Multiple Sclerosis Drug: The Food and Drug Administration approves orally administered multi... http://bit.ly/cGeBVE
FDA Approves Novartis Multiple Sclerosis Drug - Forbes.com
forbes.com — “The Food and Drug Administration approves orally administered multiple sclerosis drug Gilenya.” View full resource at forbes.com
Most Recently Shared on September 22, 2010 at 8:02 pm By:
Drugs and Devices OW OW Health
FDA Approves Novartis Multiple Sclerosis Drug: The Food and Drug Administration approves orally administered ... http://bit.ly/9rmV81 #drug
FDA approves Gilenya capsules for reducing MS relapses
news-medical.net — “The U.S. Food and Drug Administration has approved Gilenya capsules (fingolimod) to reduce relapses and delay disability progression in patients with relapsing forms of multiple sclerosis (MS).” View full resource at news-medical.net
Most Recently Shared on September 22, 2010 at 1:40 pm By:
FDA approves Gilenya capsules for reducing MS relapses: The U.S. Food and Drug Administration has approved Gilenya... http://bit.ly/cOWC1h
Multiple Sclerosis Drug Novartis Gains FDA Approval | ThirdAge
thirdage.com — “Multiple Sclerosis drug Novartis has been approved by The Food and Drug Administration. Federal health regulators have approved the first pill to treat the underlying causes of multiple sclerosis, a debilitating nervous system disorder that has” View full resource at thirdage.com
Most Recently Shared on September 22, 2010 at 9:32 pm By:
Multiple sclerosis drug Novartis gains FDA approval! http://dld.bz/wDdx
Multiple Sclerosis Drug Novartis Gains FDA Approval | ThirdAge
thirdage.com — “Multiple Sclerosis drug Novartis has been approved by The Food and Drug Administration. Federal health regulators have approved the first pill to treat the underlying causes of multiple sclerosis, a debilitating nervous system disorder that has” View full resource at thirdage.com
Most Recently Shared on September 22, 2010 at 8:07 pm By:
Multiple Sclerosis Drug Novartis Gains FDA Approval: Multiple Sclerosis drug Novartis has been approved by The Foo... http://bit.ly/d2TMIA
Gilenya, First Oral MS Drug, Gets FDA Nod - QualityPoint Technologies
qualitypointtech.net — “The FDA today approved Gilenya, the first oral MS drug. The once-daily capsules cut MS relapses and delay disease progression, but up risk of infections and other serious side effects. (Source: WebMD Health)MedWorm Message: Register forMedMatcha, MedWorm's medical advertising network, and receive $5 free advertising.” View full resource at qualitypointtech.net
Most Recently Shared on September 22, 2010 at 7:24 pm By:
Gilenya, First Oral MS Drug, Gets FDA Nod: The FDA today approved Gilenya, the first oral MS drug. The once-daily ... http://bit.ly/bWBeyK
MS "Pill" Approved - Multiple Sclerosis Blog
everydayhealth.com — “The first oral, disease-modifying MS drug, Fingolimod, was approved for release and marketing by the FDA's Advisory Committee.” View full resource at everydayhealth.com
Most Recently Shared on June 17, 2010 at 12:41 am By:
MS Blog Update: MS "Pill" Approved - The first oral, disease-modifying MS drug, Fingolimod, was approved for release... http://ht.ly/17LJc2
Novartis' Gilenya uptake to increase
news-medical.net — “A study published this week by ITG revealed that Novartis recently approved drug, Gilenya, has already taken share from market leaders in the multiple sclerosis (MS) market, and uptake is expected to increase significantly over the next year. Gilenya came onto the market in late September as the first FDA-approved oral disease-modifying MS drug, and Novartis initially faced safety concerns and monitoring requirements that deterred some physicians from adopting the new drug.” View full resource at news-medical.net
Most Recently Shared on December 20, 2010 at 10:50 am By:
Novartis' Gilenya uptake to increase: A study published this week by ITG revealed that Novartis recently approve... http://bit.ly/i48uE6
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Related WisdomCards
Related Health Centers
Featuring the top 3 experts for this topic
-
medical_tweets
-
Everyday Health
Everyday Health inspires your health goals and supports your progress through expert guidance and breaking health news. Tweets managed by @anniehauser
-
MPR
eMPR.com provides up-to-date, concise drug information at the point-of-care.
Advertisement
